نتایج جستجو برای: anti vegf

تعداد نتایج: 383792  

2017
Yasmin A. Lyons Sunila Pradeep Sherry Y. Wu Monika Haemmerle Jean M. Hansen Michael J. Wagner Alejandro Villar-Prados Archana S. Nagaraja Robert L. Dood Rebecca A. Previs Wei Hu Yang Zhao Duncan H. Mak Zhilan Xiao Brenda D. Melendez Gregory A. Lizee Imelda Mercado-Uribe Keith A. Baggerly Patrick Hwu Jinsong Liu Willem W. Overwijk Robert L. Coleman Anil K. Sood

Anti-angiogenesis therapy has shown clinical benefit in patients with high-grade serous ovarian cancer (HGSC), but adaptive resistance rapidly emerges. Thus, approaches to overcome such resistance are needed. We developed the setting of adaptive resistance to anti-VEGF therapy, and performed a series of in vivo experiments in both immune competent and nude mouse models. Given the pro-angiogenic...

Journal: :Molecules 2017
Yeyin Liang Yubo Zhang Guocai Wang Yaolan Li Weihuan Huang

Anti-angiogenesis targeting vascular endothelial growth factor receptor-2 (VEGFR-2) has been considered as an important strategy for cancer therapy. Penduliflaworosin is a diterpenoid isolated from the plant Croton crassifolius. Our previous study showed that this diterpenoid possesses strong anti-angiogenic activity by inhibiting vessel formation in zebrafish. This study was conducted to furth...

2009
Mansour Homayouni

The introduction of pharmacotherapy has been one of the most important advances in the management of retinal disorders. Age-related macular degeneration (AMD) was once considered as an irrepressible disease leading to permanent macular damage, however anti-vascular endothelial growth factor (anti-VEGF) agents are now believed to halt the progression of the condition and improve vision in a cons...

2016
Yunlong Yang Yin Zhang Hideki Iwamoto Kayoko Hosaka Takahiro Seki Patrik Andersson Sharon Lim Carina Fischer Masaki Nakamura Mitsuhiko Abe Renhai Cao Peter Vilhelm Skov Fang Chen Xiaoyun Chen Yongtian Lu Guohui Nie Yihai Cao

The impact of discontinuation of anti-VEGF cancer therapy in promoting cancer metastasis is unknown. Here we show discontinuation of anti-VEGF treatment creates a time-window of profound structural changes of liver sinusoidal vasculatures, exhibiting hyper-permeability and enlarged open-pore sizes of the fenestrated endothelium and loss of VE-cadherin. The drug cessation caused highly leaky hep...

2013
Joo Young Shin Se Joon Woo Jeeyun Ahn Kyu Hyung Park

PURPOSE To describe optical coherence tomography (OCT) characteristics of neovascular age-related macular degeneration (AMD) patients refractory to intravitreal anti-vascular endothelial growth factor (VEGF) injections (ranibizumab, bevacizumab) and their responses to alternative anti-VEGF agents or photodynamic therapy (PDT). METHODS A retrospective review of 267 neovascular AMD patients tre...

2012
Cinthia V. Pastuskovas Sarajane Ross Eric Cheng Kathryn Parsons-Reponte Gary Cain Marjie Van Hoy Nicholas Majidy Sheila Bheddah Josefa dela Cruz Chuh Katherine R. Kozak Nicholas Lewin-Koh Daniela Bumbaca Mark Sliwkowski Jay Tibbitts Frank-Peter Theil Paul J. Fielder Leslie A. Khawli Andrew Boswell

Both human epidermal growth factor receptor 2 (HER-2/neu) and VEGF overexpression correlate with aggressive phenotypes and decreased survival among breast cancer patients. Concordantly, the combination of trastuzumab (anti-HER2) with bevacizumab (anti-VEGF) has shown promising results in preclinical xenograft studies and in clinical trials. However, despite the known antiangiogenic mechanism of...

2017
Mingxing Wu Haibo Xiong Yan Xu Xiaojing Xiong Hongmi Zou Minming Zheng Xiuqing Wang Xiyuan Zhou

AIMS The purpose of this study is to investigate whether gene polymorphisms of the vascular endothelial growth factor A (VEGF-A) and its receptor (VEGFR-2) have a pharmacogenetics effect on the anti-VEGF treatment for neovascular age-related macular degeneration (nAMD). METHODS We carried out a meta-analysis focusing on the relationship between VEGF-related gene polymorphisms and treatment re...

Journal: :Diabetes care 2014
Rafael Simó Jeffrey M Sundstrom David A Antonetti

Diabetic retinopathy is the leading cause of visual impairment and preventable blindness, and represents a significant socioeconomic cost for health care systems worldwide. Therefore, new approaches beyond current standards of diabetes care are needed. Based on the crucial pathogenic role of vascular endothelial growth factor (VEGF) in the development of diabetic macular edema (DME), intravitre...

Journal: :World journal of pediatrics : WJP 2014
Ai-Yi Zhou Yu-Jing Bai Min Zhao Wen-Zhen Yu Lv-Zhen Huang Xiao-Xin Li

BACKGROUND Clinical trials have revealed that the antivascular endothelial growth factor (VEGF) therapies are effective in retinopathy of prematurity (ROP). But the low level of VEGF was necessary as a survival signal in healthy conditions, and endogenous placental growth factor (PIGF) is redundant for development. The purpose of this study was to elucidate the PIGF expression under hypoxia as ...

Journal: :Endocrinology 2005
Hyun-Ock Pae Gi-Su Oh Byung-Min Choi Young-Myeong Kim Hun-Taeg Chung

Heme oxygenase (HO)-1 has been shown to be an important biological target of nitric oxide (NO). NO can induce HO-1 expression and IL-8 production, particularly, in endothelial cells. Interestingly, HO-1 tends to induce the production of vascular endothelial growth factor (VEGF) that is involved in endothelial IL-8 syntheses. Whether HO-1 expression by NO may provide a link with IL-8 or VEGF syn...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید